首页> 美国卫生研究院文献>other >Similar Properties of Chondrocytes from Osteoarthritis Joints and Mesenchymal Stem Cells from Healthy Donors for Tissue Engineering of Articular Cartilage
【2h】

Similar Properties of Chondrocytes from Osteoarthritis Joints and Mesenchymal Stem Cells from Healthy Donors for Tissue Engineering of Articular Cartilage

机译:骨关节炎关节软骨细胞和健康捐献者间充质干细胞用于关节软骨组织工程的相似特性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lesions of hyaline cartilage do not heal spontaneously, and represent a therapeutic challenge. In vitro engineering of articular cartilage using cells and biomaterials may prove to be the best solution. Patients with osteoarthritis (OA) may require tissue engineered cartilage therapy. Chondrocytes obtained from OA joints are thought to be involved in the disease process, and thus to be of insufficient quality to be used for repair strategies. Bone marrow (BM) derived mesenchymal stem cells (MSCs) from healthy donors may represent an alternative cell source. We have isolated chondrocytes from OA joints, performed cell culture expansion and tissue engineering of cartilage using a disc-shaped alginate scaffold and chondrogenic differentiation medium. We performed real-time reverse transcriptase quantitative PCR and fluorescence immunohistochemistry to evaluate mRNA and protein expression for a range of molecules involved in chondrogenesis and OA pathogenesis. Results were compared with those obtained by using BM-MSCs in an identical tissue engineering strategy. Finally the two populations were compared using genome-wide mRNA arrays. At three weeks of chondrogenic differentiation we found high and similar levels of hyaline cartilage-specific type II collagen and fibrocartilage-specific type I collagen mRNA and protein in discs containing OA and BM-MSC derived chondrocytes. Aggrecan, the dominant proteoglycan in hyaline cartilage, was more abundantly distributed in the OA chondrocyte extracellular matrix. OA chondrocytes expressed higher mRNA levels also of other hyaline extracellular matrix components. Surprisingly BM-MSC derived chondrocytes expressed higher mRNA levels of OA markers such as COL10A1, SSP1 (osteopontin), ALPL, BMP2, VEGFA, PTGES, IHH, and WNT genes, but lower levels of MMP3 and S100A4. Based on the results presented here, OA chondrocytes may be suitable for tissue engineering of articular cartilage.
机译:透明软骨损伤无法自愈,代表了治疗挑战。使用细胞和生物材料对关节软骨进行体外工程设计可能是最好的解决方案。骨关节炎(OA)患者可能需要组织工程软骨治疗。从OA关节获得的软骨细胞被认为与疾病过程有关,因此其质量不足以用于修复策略。来自健康供体的骨髓(BM)衍生的间充质干细胞(MSC)可能代表了另一种细胞来源。我们已经从OA关节中分离了软骨细胞,使用了盘状藻酸盐支架和软骨分化培养基进行了细胞培养扩增和软骨组织工程设计。我们进行了实时逆转录酶定量PCR和荧​​光免疫组织化学,以评估与软骨形成和OA发病机理有关的一系列分子的mRNA和蛋白质表达。将结果与在相同组织工程策略中使用BM-MSC获得的结果进行比较。最后,使用全基因组mRNA阵列比较了这两个种群。在软骨形成的三周分化中,我们在含有OA和BM-MSC软骨细胞的椎间盘中发现了高水平和相似水平的透明软骨特异性II型胶原蛋白和纤维软骨特异性I型胶原蛋白mRNA和蛋白质。 Aggrecan是透明软骨中的主要蛋白聚糖,在OA软骨细胞胞外基质中分布更为丰富。 OA软骨细胞也表达其他透明细胞外基质成分的更高的mRNA水平。出乎意料的是,BM-MSC衍生的软骨细胞表达较高水平的OA标记物,例如COL10A1,SSP1(骨桥蛋白),ALPL,BMP2,VEGFA,PTGES,IHH和WNT基因,但较低水平的MMP3和S100A4。根据此处显示的结果,OA软骨细胞可能适用于关节软骨的组织工程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号